Company Overview and News
We issued an updated research report on Cimpress N.V. (CMPR - Free Report) on Aug 16. Netherlands-based Cimpress is an online provider of high-quality graphic design services, and customized printed products to small businesses and consumers. The stock, with approximately $4.3-billion market capitalization, currently carries a Zacks Rank #3 (Hold). Let’s delve deeper and discuss the company’s potential growth drivers, and possible headwinds.
[DXPE] HD DXPE PSTG AIMC CFX HEAR OXY
Strength in business and consumer spending, along with growth in exports, is driving U.S. economic growth, of late. Moving ahead, the robust economic momentum is anticipated to spur infrastructure spending across the country. Against this backdrop, inventing in selective industrial stocks seems sensible now.
ROLL HD PSTG ADES AIMC ALG HEAR OXY
Strength in business and consumer spending, along with growth in exports, has been driving U.S. economic growth, of late. Going forward, the robust economic momentum is anticipated to spur infrastructure spending across the country. Against this backdrop, inventing in selective industrial stocks seems sensible now.
HD PSTG ADES AIMC IRBT ALG HEAR OXY
Zebra Technologies Corporation (ZBRA - Free Report) recently marked its 10th year of business deal with Auto Parte Y Mas S.A.’s (“APYMSA”) distribution center through which the company provides technologies for improving the workforce and operational processes of the latter. Prior to this, on Aug 14, Zebra Technologies successfully completed the acquisition of Xplore Technologies Corporation.
XPLR HD ADES AIMC ALG ZBRA OXY
After climbing 1% in June, growth in American productivity slowed down last month after being hit by Trump’s tariff threats. Industrial production (a measure of output at factories, mines and utilities) inched up 0.1% in July as weakness in the mining and utilities sectors offset most of the growth in manufacturing output. Inside the Numbers Manufacturing output grew 0.3% in July driven by higher production of cars, electronics, and appliances.
AVY HD CATR TEX AIMC CAT FIDU VIS
U.S. GDP growth tapped the best gain in the past four years during the April-June quarter. Solid business and consumer spending, along with growth in exports, helped drive economic growth in the country.
IR.WI HD ADES AIMC IR ALG INGERRAND 500210
ARC Document Solutions, Inc. (ARC - Free Report) has impressed investors with its recent earnings results, wherein both the top line and bottom line surpassed the Zacks Consensus Estimate. We believe that strong traction across the company’s business lines and solid portfolio of new products might continue to be growth drivers.
HD ARC AIMC B
Roper Technologies, Inc. (ROP - Free Report) , on Aug 14, priced an offering of $1.5 billion of its senior unsecured notes, including $700 million of 3.650% senior notes due to expire on Sep 15, 2023, and $800 million of 4.20% senior notes due to expire on Sep 15, 2028. Subject to customary closing conditions, this offering is anticipated to close on Aug 28, 2018. As communicated by the company, notes due to expire in 2023 have been priced at 99.
[DXPE] ROP HD DXPE AIMC CFX
We believe that Harsco Corporation (HSC - Free Report) is a solid choice for investors seeking exposure in the industrial services space. The stock, with roughly $2-billion market capitalization, was upgraded to a Zacks Rank #1 (Strong Buy) on Aug 15. Moreover, the stock’s investment appeal is accentuated by a favorable VGM Score of A. The company delivered better-than-expected results in the last four quarters, with an average positive earnings surprise of 17.
[DXPE] DXPE HSC AIMC CFX
We issued an updated research report on Flowserve Corporation (FLS - Free Report) on Aug 13. Headquartered at Irving, TX, Flowserve is a leading manufacturer and aftermarket service provider of comprehensive flow control systems, globally. Let’s delve deeper and discuss the company’s potential growth drivers and possible headwinds. Factors Favoring Flowserve Strengthening End Markets: Flowserve primarily serves customers in the oil and gas, chemical, power, and general industrial markets through its three reportable segments.
[DXPE] DXPE AIMC CFX FLS
The U.S. GDP growth tapped the best gain in the past four years during the April-June quarter. Solid business and consumer spending, along with growth in exports, helped drive economic growth in the country.
[DXPE] DXPE AIMC CFX AIT
DXP Enterprises, Inc. (DXPE - Free Report) has impressed investors with its recent earnings results, wherein the top line and bottom line surpassed the Zacks Consensus Estimate. We believe that strong traction across the company’s operational segments and accretive acquisitions might continue to be growth drivers, going ahead.
[DXPE] ROLL FOX DXPE AIMC AIT LMHA LMHB FOXA LM
Plug Power Inc. (PLUG - Free Report) reported a loss of 12 cents per share in second-quarter 2018 results, wider than the Zacks Consensus Estimate of a loss of 8 cents by 50%. The figure was wider than a loss of 10 cents incurred in the year-ago quarter. Total Revenues Plug Power’s quarterly revenues of $39.9 million lagged the Zacks Consensus Estimate of $42 million by 5%. The figure surged 75% from $23 million in the year-ago quarter.
ROP FOX AIMC LMHA PLUG LMHB FOXA LM
10h - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
11h - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
11h - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...
as of ET